130 related articles for article (PubMed ID: 27482028)
1. Antibiotic-loaded bone void filler accelerates healing in a femoral condylar rat model.
Shiels SM; Cobb RR; Bedigrew KM; Ritter G; Kirk JF; Kimbler A; Finger Baker I; Wenke JC
Bone Joint J; 2016 Aug; 98-B(8):1126-31. PubMed ID: 27482028
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of fracture healing by continuous delivery of demineralized bone matrix proteins and tobramycin.
Galjour C; Dzugan S; Graves M; Benghuzzi H; Russell G; Tucci M; Tsao A
Biomed Sci Instrum; 2005; 41():122-7. PubMed ID: 15850092
[TBL] [Abstract][Full Text] [Related]
3. Local antibiotic delivery with demineralized bone matrix.
Lewis CS; Supronowicz PR; Zhukauskas RM; Gill E; Cobb RR
Cell Tissue Bank; 2012 Mar; 13(1):119-27. PubMed ID: 21197583
[TBL] [Abstract][Full Text] [Related]
4. A resorbable antibiotic eluting bone void filler for periprosthetic joint infection prevention.
Jones Z; Brooks AE; Ferrell Z; Grainger DW; Sinclair KD
J Biomed Mater Res B Appl Biomater; 2016 Nov; 104(8):1632-1642. PubMed ID: 26332762
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of local antibiotic delivery with an osteoinductive and osteoconductive bone-graft substitute.
Beardmore AA; Brooks DE; Wenke JC; Thomas DB
J Bone Joint Surg Am; 2005 Jan; 87(1):107-12. PubMed ID: 15634820
[TBL] [Abstract][Full Text] [Related]
6. Histological and radiographic comparison of allograft substitutes using a continuous delivery model in segmental defects.
Marks T; Wingerter S; Franklin L; Woodall J; Tucci M; Russell G; Patel R; Benghuzzi H
Biomed Sci Instrum; 2007; 43():194-9. PubMed ID: 17487080
[TBL] [Abstract][Full Text] [Related]
7. In vivo efficacy of tobramycin-loaded synthetic calcium phosphate beads in a rabbit model of staphylococcal osteomyelitis.
Lulu GA; Karunanidhi A; Mohamad Yusof L; Abba Y; Mohd Fauzi F; Othman F
Ann Clin Microbiol Antimicrob; 2018 Dec; 17(1):46. PubMed ID: 30593272
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic-eluting resorbable bone-void filler evaluated in a large animal infection prevention model.
Ferrell Z; Grainger DW; Sinclair KD
Eur Cell Mater; 2019 Apr; 37():265-276. PubMed ID: 30957870
[TBL] [Abstract][Full Text] [Related]
9. Analysis of parameters influencing the release of antibiotics mixed with bone grafting material using a reliable mixing procedure.
Bormann N; Schwabe P; Smith MD; Wildemann B
Bone; 2014 Feb; 59():162-72. PubMed ID: 24239495
[TBL] [Abstract][Full Text] [Related]
10. Dual-purpose bone grafts improve healing and reduce infection.
Guelcher SA; Brown KV; Li B; Guda T; Lee BH; Wenke JC
J Orthop Trauma; 2011 Aug; 25(8):477-82. PubMed ID: 21738070
[TBL] [Abstract][Full Text] [Related]
11. Local delivery of tobramycin from injectable biodegradable polyurethane scaffolds.
Hafeman AE; Zienkiewicz KJ; Carney E; Litzner B; Stratton C; Wenke JC; Guelcher SA
J Biomater Sci Polym Ed; 2010; 21(1):95-112. PubMed ID: 20040156
[TBL] [Abstract][Full Text] [Related]
12. Local antibiotic delivery with bovine cancellous chips.
Lewis CS; Katz J; Baker MI; Supronowicz PR; Gill E; Cobb RR
J Biomater Appl; 2011 Nov; 26(4):491-506. PubMed ID: 20819915
[TBL] [Abstract][Full Text] [Related]
13. Local delivery of the cationic steroid antibiotic CSA-90 enables osseous union in a rat open fracture model of Staphylococcus aureus infection.
Schindeler A; Yu NY; Cheng TL; Sullivan K; Mikulec K; Peacock L; Matthews R; Little DG
J Bone Joint Surg Am; 2015 Feb; 97(4):302-9. PubMed ID: 25695982
[TBL] [Abstract][Full Text] [Related]
14. Elution of vancomycin and tobramycin bonded to vascular grafts.
Leblebicioglu H; Sencan I; Gunaydin M; Esen S; Eroglu C; Sunbul M
J Chemother; 1999 Feb; 11(1):46-9. PubMed ID: 10078780
[TBL] [Abstract][Full Text] [Related]
15. Ability of recombinant human bone morphogenetic protein 2 to enhance bone healing in the presence of tobramycin: evaluation in a rat segmental defect model.
Glatt V; Kwong FN; Park K; Parry N; Griffin D; Vrahas M; Evans CH; Harris M
J Orthop Trauma; 2009; 23(10):693-701. PubMed ID: 19858977
[TBL] [Abstract][Full Text] [Related]
16. Prophylaxis of implant-related staphylococcal infections using tobramycin-containing bone cement.
Nijhof MW; Dhert WJ; Fleer A; Vogely HC; Verbout AJ
J Biomed Mater Res; 2000 Dec; 52(4):754-61. PubMed ID: 11033559
[TBL] [Abstract][Full Text] [Related]
17. Prevention of infection with tobramycin-containing bone cement or systemic cefazolin in an animal model.
Nijhof MW; Stallmann HP; Vogely HC; Fleer A; Schouls LM; Dhert WJ; Verbout AJ
J Biomed Mater Res; 2000 Dec; 52(4):709-15. PubMed ID: 11033554
[TBL] [Abstract][Full Text] [Related]
18. Hydrogel delivery of lysostaphin eliminates orthopedic implant infection by
Johnson CT; Wroe JA; Agarwal R; Martin KE; Guldberg RE; Donlan RM; Westblade LF; García AJ
Proc Natl Acad Sci U S A; 2018 May; 115(22):E4960-E4969. PubMed ID: 29760099
[TBL] [Abstract][Full Text] [Related]
19. Local antibiotic delivery by a bioabsorbable gel is superior to PMMA bead depot in reducing infection in an open fracture model.
Penn-Barwell JG; Murray CK; Wenke JC
J Orthop Trauma; 2014 Jun; 28(6):370-5. PubMed ID: 23948961
[TBL] [Abstract][Full Text] [Related]
20. [Elution kinetics and antimicrobial effects of gentamicin- and clindamycin-loaded bone cements in vitro].
Schiefer UR; Heiss C; Dingeldein E; Wenisch S; Schnettler R; Kilian O
Z Orthop Unfall; 2008; 146(1):92-8. PubMed ID: 18324589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
